Home/Filings/4/0000950170-23-073844
4//SEC Filing

Bryce Joanne 4

Accession 0000950170-23-073844

CIK 0001816736other

Filed

Dec 28, 7:00 PM ET

Accepted

Dec 29, 4:15 PM ET

Size

6.9 KB

Accession

0000950170-23-073844

Insider Transaction Report

Form 4
Period: 2023-12-27
Bryce Joanne
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-12-273,00073,745 total
    Exercise: $9.86Exp: 2031-09-13Common Stock (3,000 underlying)
  • Exercise/Conversion

    Common Stock

    2023-12-27$9.86/sh+3,000$29,5805,500 total
Footnotes (1)
  • [F1]The shares underlying this option vest in 48 equal monthly installments following September 1, 2021, subject to the Reporting Person's continued service on each such vesting date.

Documents

1 file

Issuer

Disc Medicine, Inc.

CIK 0001816736

Entity typeother

Related Parties

1
  • filerCIK 0001951845

Filing Metadata

Form type
4
Filed
Dec 28, 7:00 PM ET
Accepted
Dec 29, 4:15 PM ET
Size
6.9 KB